| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,416 |
2,825 |
$65K |
| 99454 |
|
619 |
492 |
$13K |
| 99457 |
|
618 |
491 |
$11K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
129 |
112 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
124 |
104 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
41 |
35 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
50 |
41 |
$1K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
17 |
16 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
50 |
50 |
$667.46 |
| 99453 |
|
81 |
80 |
$500.35 |
| 99458 |
|
36 |
25 |
$466.48 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
18 |
14 |
$139.74 |
| 99072 |
|
644 |
528 |
$46.86 |
| 1160F |
|
45 |
38 |
$0.02 |
| 1159F |
|
45 |
38 |
$0.02 |
| 1126F |
|
12 |
12 |
$0.00 |